Zuzana Babinska

2 papers in the library · 26 citations · publishing 2014-2017

Papers

Sort Most recent Most cited

Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia

Neurotoxicity Research July 1, 2017 Jana Ruda-Kucerova, Zuzana Babinska, Tibor Stark et al. 26 citations

Ketamine may prove to be a potential candidate in treating the widespread drug addiction/substance abuse epidemic among patients with schizophrenia. Clinical studies have shown ketamine to reduce cocaine and heroin cravings. However, the use of ketamine remains controversial as it may exacerbate the symptoms of schizophrenia. Therefore, the aim of this study is to characterize the effects of...

DOI: 10.1007/s12640-017-9718-9 Full text Ketamine Mam model Methamphetamine Self-administration +1

Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms.

Frontiers in Pharmacology 2014 Petra Amchova, Jana Kučerová, Valentina Giugliano et al.

Depression has been associated with drug consumption, including heavy or problematic cannabis use. According to an animal model of depression and substance use disorder comorbidity, we combined the olfactory bulbectomy (OBX) model of depression with intravenous drug self-administration procedure to verify whether depressive-like rats displayed altered voluntary intake of the CB1 receptor...

DOI: 10.3389/fphar.2014.00044 Full text Depression Serotonin Win55212-2 Cannabinoid +4